Yüklüyor......
Bryostatin‐1 ameliorated experimental colitis in Il‐10 (−/−) Mice by protecting the intestinal barrier and limiting immune dysfunction
Bryostatin‐1 (Bry‐1) has been proven to be effective and safe in clinical trials of a variety of immune‐related diseases. However, little is known about its effect on Crohn's disease (CD). We aimed to investigate the impact of Bry‐1 on CD‐like colitis and determine the mechanism underlying this...
Kaydedildi:
| Yayımlandı: | J Cell Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652299/ https://ncbi.nlm.nih.gov/pubmed/31251471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14457 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|